関連する実験動画
Updated: Jun 23, 2026
08:32
Subpial Adeno-associated Virus 9 (AAV9) Vector Delivery in Adult Mice
Published on: July 13, 2017
Alpha 9: アセチルコリン受容体で,ラットの内毛細胞で発現する新薬学的特性を有する
A B Elgoyhen1, D S Johnson, J Boulter
1Salk Institute for Biological Studies, La Jolla, California 92037.
Cell
|November 18, 1994
まとめ
研究者らは,アルファ9ニコチンアセチルコリン受容体サブユニットを分離し,特徴づけました. この受容体は頭毛細胞に存在し,聴覚刺激のエンコーディングを調節する可能性があります.
科学分野:
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
- 監査科学とは,監査に関する科学です.
背景:
- コリナージック受容体は,感覚システムにおいて重要な役割を果たします.
- ニコチンアセチルコリン受容体 (nAChRs) は,リガンドゲートイオンチャネルの多様なファミリーです.
- 感覚毛細胞における特定のnAChRサブユニットの特定の機能は,まだ完全に解明されていない.
研究 の 目的:
- 新型ニコチンアセチルコリン受容体サブユニットを分離し,機能的に特徴づけ,アルファ9と指定.
- アルファ9受容体の薬理学的性質と発現パターンを調査する.
- 聴覚系におけるアルファ9受容体の潜在的役割を決定する.
主な方法:
- アルファ9遺伝子の分離とクローニング.
- クセノプスの卵細胞におけるアルファ9cRNAの発現.
- アセチルコリン活性化による機能的特徴化.
- エクスプレスされた受容体の薬理学的プロファイリング.
- 遺伝子発現パターンを決定するために,in situ ハイブリダイゼーションを行います.
主要な成果:
- アルファ9ニコチン・アセチルコリン受容体サブユニットを成功裏に分離し,機能的に特徴づけました.
- アルファ9サブユニットは,アセチルコリンによって活性化された同型受容体-チャネル複合体を形成する.
- アルファ9受容体は,ニコチンとムスカリンの混合した独特の薬理学プロファイルを示しています.
- アルファ9遺伝子の発現は,ネズミの内にある外部の毛細胞を含む特定の細胞に制限されています.
- アルファ9受容体の性質は,脊椎動物の内毛細胞のコレリン性受容体と一致する.
結論:
- アルファ9ニコチンアセチルコリン受容体は,頭毛細胞のコレナー効果内置の重要な構成要素です.
- この受容体は,聴覚刺激のエンコーディングを調節する上で重要な役割を果たしている可能性が高い.
- 独特の薬理学的性質は,聴覚経路内の特殊な機能を示唆しています.
さらに関連する動画
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
09:06Localization of Plasma Membrane and Intracellular Neuronal Nicotinic Acetylcholine Receptors Using Quantitative Imaging in Mammalian Cells
Published on: December 19, 2025
関連する概念動画
01:19Ligand-gated Ion Channels
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:17Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline moieties. Phenoxybenzamine, with a haloalkylamine...